Although strategies targeting immune reconstitution to suppress T cell–mediated inflammation in AKI have been tested previously with conventional immunosuppressive drugs, mTOR inhibitor or mycophenolate mofetil, they failed to show a protective effect (56, 57). Here, MTOR is linked to acute kidney injury.